Home / Diabetes In Control (page 1214)

Diabetes In Control

FDA OKs Lilly-Amylin Drug Byetta for Type 2 Diabetes

A drug derived from lizard saliva has been approved by U.S. regulators to treat diabetes in patients who have not responded to other treatments, the drug’s developers, Eli Lilly and Co. and Amylin Pharmaceuticals Inc., said on Friday. See special this week’s feature. Lizard Spit leads to Improved Glucose Control

Read More »